• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

组织因子、凝血因子 VIII 和 IX 在微泡诱导的胰腺癌血栓形成及肿瘤生长中的作用

Tissue factor, factor VIII and IX in microvesicle-induced thrombosis and tumor growth of pancreatic cancer.

作者信息

Chou Sheng-Chieh, Chang Shu-Lun, Yu Cheng-Yeh, Lin Chao-I, Chang Yen-Ting, Chen Li-Fu, Li Jia-Yi, Pai Chen-Hsueh, Lin Shu-Rung, Cheng Wern-Cherng, Yuan Chang-Tsu, Lin Shu-Wha

机构信息

Division of Hematology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.

Graduate Institute of Clinical Medicine, College of Medicine, National Taiwan University, Taipei, Taiwan.

出版信息

Thromb J. 2025 Apr 11;23(1):32. doi: 10.1186/s12959-025-00715-x.

DOI:10.1186/s12959-025-00715-x
PMID:40217494
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11987238/
Abstract

BACKGROUND

Tissue factor (TF)-rich cancer microvesicles are correlated with thrombosis risk. Intrinsic coagulation factors are also associated with the risk of thrombosis in cancer patients. This study explored the roles of pancreatic cancer-derived microvesicles and intrinsic factors in thrombogenesis.

METHODS

Human pancreatic cancer cell lines rich in TF (AsPC-1-TF, MIAPaCa-2-TF) or poor in TF [AsPC-1-TF(knockout) and MIAPaCa-2-TF] were generated for microvesicle preparation and injected into coagulation-defective mice. Inferior vena cava (IVC) clots and lung thrombosis were evaluated. Immunodeficient hemophilia A (NSG-HA) mice were orthotopically injected with the cells mentioned above, and the tumor and IVC clot weights were analyzed.

RESULTS

With the injection of TF microvesicles, IVC clots were rarely found in hemophilic mice. The TF and TF microvesicles resulted in few IVC clots in any mouse. Lung thrombosis was substantially reduced in the hemophilic mice infused with any microvesicle type. In orthotopic tumor models, TF cells grew faster than did TF cells. TF tumor-bearing NSG-WT mice had the most enormous IVC clots, whereas NSG-HA mice had no IVC clots.

CONCLUSION

Pancreatic cancer thrombosis induced by TF-expressing microvesicles strongly depended on FVIII and FIX, while VWF played a minor role. Moreover, TF, but not FVIII, was significantly related to tumor growth.

摘要

背景

富含组织因子(TF)的癌症微泡与血栓形成风险相关。内源性凝血因子也与癌症患者的血栓形成风险有关。本研究探讨了胰腺癌来源的微泡和内源性因子在血栓形成中的作用。

方法

构建富含TF的人胰腺癌细胞系(AsPC-1-TF、MIAPaCa-2-TF)或TF缺乏的细胞系[AsPC-1-TF(敲除)和MIAPaCa-2-TF]用于制备微泡,并将其注射到凝血缺陷小鼠体内。评估下腔静脉(IVC)血栓和肺血栓形成情况。将上述细胞原位注射到免疫缺陷的甲型血友病(NSG-HA)小鼠体内,分析肿瘤和IVC血栓重量。

结果

注射TF微泡后,血友病小鼠中很少发现IVC血栓。TF和TF微泡在任何小鼠中均导致较少的IVC血栓。输注任何类型微泡的血友病小鼠肺血栓形成均显著减少。在原位肿瘤模型中,TF细胞比TF细胞生长更快。TF荷瘤NSG-WT小鼠的IVC血栓最大,而NSG-HA小鼠没有IVC血栓。

结论

表达TF的微泡诱导的胰腺癌血栓形成强烈依赖于FVIII和FIX,而VWF起次要作用。此外,TF而非FVIII与肿瘤生长显著相关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/24ad/11987238/e44111eeadbd/12959_2025_715_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/24ad/11987238/f78c0b60bc27/12959_2025_715_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/24ad/11987238/ab7548bc7dd5/12959_2025_715_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/24ad/11987238/b1404c9b3f70/12959_2025_715_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/24ad/11987238/e1a381c8e814/12959_2025_715_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/24ad/11987238/fbd94756ba0f/12959_2025_715_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/24ad/11987238/e44111eeadbd/12959_2025_715_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/24ad/11987238/f78c0b60bc27/12959_2025_715_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/24ad/11987238/ab7548bc7dd5/12959_2025_715_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/24ad/11987238/b1404c9b3f70/12959_2025_715_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/24ad/11987238/e1a381c8e814/12959_2025_715_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/24ad/11987238/fbd94756ba0f/12959_2025_715_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/24ad/11987238/e44111eeadbd/12959_2025_715_Fig6_HTML.jpg

相似文献

1
Tissue factor, factor VIII and IX in microvesicle-induced thrombosis and tumor growth of pancreatic cancer.组织因子、凝血因子 VIII 和 IX 在微泡诱导的胰腺癌血栓形成及肿瘤生长中的作用
Thromb J. 2025 Apr 11;23(1):32. doi: 10.1186/s12959-025-00715-x.
2
Human pancreatic tumors grown in mice release tissue factor-positive microvesicles that increase venous clot size.在小鼠体内生长的人类胰腺肿瘤释放组织因子阳性的微囊泡,增加静脉血栓的大小。
J Thromb Haemost. 2017 Nov;15(11):2208-2217. doi: 10.1111/jth.13809. Epub 2017 Sep 20.
3
Tissue factor-positive tumor microvesicles activate platelets and enhance thrombosis in mice.组织因子阳性肿瘤微泡激活小鼠血小板并增强血栓形成。
J Thromb Haemost. 2016 Jan;14(1):153-66. doi: 10.1111/jth.13181. Epub 2015 Dec 11.
4
Tissue factor expressed by circulating cancer cell-derived microparticles drastically increases the incidence of deep vein thrombosis in mice.循环癌细胞衍生微粒所表达的组织因子会大幅增加小鼠深静脉血栓形成的发生率。
J Thromb Haemost. 2015 Jul;13(7):1310-9. doi: 10.1111/jth.13002. Epub 2015 Jun 8.
5
OC-04 - Tissue factor positive microvesicles activate platelets in vitro and in vivo and enhance thrombosis in mice.OC-04 - 组织因子阳性微囊泡在体外和体内激活血小板,并增强小鼠的血栓形成。
Thromb Res. 2016 Apr;140 Suppl 1:S169-70. doi: 10.1016/S0049-3848(16)30121-9. Epub 2016 Apr 8.
6
Tumor-derived tissue factor activates coagulation and enhances thrombosis in a mouse xenograft model of human pancreatic cancer.肿瘤源性组织因子激活凝血并增强人胰腺癌细胞异种移植模型中的血栓形成。
Blood. 2012 Jun 7;119(23):5543-52. doi: 10.1182/blood-2012-01-402156. Epub 2012 Apr 30.
7
Analysis of the potential of cancer cell lines to release tissue factor-containing microvesicles: correlation with tissue factor and PAR2 expression.癌细胞系释放含组织因子微囊泡的潜力分析:与组织因子及PAR2表达的相关性
Thromb J. 2016 Jan 19;14:2. doi: 10.1186/s12959-016-0075-3. eCollection 2016.
8
AKT2 regulates endothelial-mediated coagulation homeostasis and promotes intrathrombotic recanalization and thrombus resolution in a mouse model of venous thrombosis.AKT2 调节内皮介导的凝血稳态,促进静脉血栓形成小鼠模型中的血栓内再通和血栓溶解。
J Thromb Thrombolysis. 2020 Jul;50(1):98-111. doi: 10.1007/s11239-020-02112-9.
9
Inferior vena cava ligation rapidly induces tissue factor expression and venous thrombosis in rats.下腔静脉结扎可迅速诱导大鼠组织因子表达并导致静脉血栓形成。
Arterioscler Thromb Vasc Biol. 2009 Jun;29(6):863-9. doi: 10.1161/ATVBAHA.109.185678. Epub 2009 Mar 5.
10
Pharmacological concentrations of recombinant factor VIIa restore hemostasis independent of tissue factor in antibody-induced hemophilia mice.在抗体诱导的血友病小鼠中,重组凝血因子VIIa的药理浓度可恢复止血功能,且不依赖组织因子。
J Thromb Haemost. 2016 Mar;14(3):546-50. doi: 10.1111/jth.13244. Epub 2016 Feb 15.

引用本文的文献

1
The effects of coagulation factors on the risk of lung cancer: a Mendelian randomization study.凝血因子对肺癌风险的影响:一项孟德尔随机化研究。
Discov Oncol. 2025 Jul 1;16(1):1213. doi: 10.1007/s12672-025-03057-2.

本文引用的文献

1
Recapitulating the immune system of hemophilia A patients with inhibitors using immunodeficient mice.利用免疫缺陷小鼠重现有抑制剂的血友病 A 患者的免疫系统。
Thromb Res. 2024 Mar;235:155-163. doi: 10.1016/j.thromres.2024.01.019. Epub 2024 Feb 8.
2
Mechanisms of cancer-associated thrombosis.癌症相关血栓形成的机制。
Res Pract Thromb Haemost. 2023 Mar 15;7(3):100123. doi: 10.1016/j.rpth.2023.100123. eCollection 2023 Mar.
3
Isolation and characterization of extracellular vesicles and future directions in diagnosis and therapy.
细胞外囊泡的分离与鉴定及其在诊断与治疗中的未来方向。
Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2023 Jan;15(1):e1835. doi: 10.1002/wnan.1835. Epub 2022 Jul 27.
4
Cancer-associated venous thromboembolism.癌症相关静脉血栓栓塞症。
Nat Rev Dis Primers. 2022 Feb 17;8(1):11. doi: 10.1038/s41572-022-00336-y.
5
Polyphosphate expression by cancer cell extracellular vesicles mediates binding of factor XII and contact activation.癌细胞细胞外囊泡表达多磷酸盐介导凝血因子 XII 的结合和接触激活。
Blood Adv. 2021 Nov 23;5(22):4741-4751. doi: 10.1182/bloodadvances.2021005116.
6
Abelacimab for Prevention of Venous Thromboembolism.Abelacimab 用于预防静脉血栓栓塞。
N Engl J Med. 2021 Aug 12;385(7):609-617. doi: 10.1056/NEJMoa2105872. Epub 2021 Jul 19.
7
Factor XII(a) inhibitors: a review of the patent literature.因子 XII(a)抑制剂:专利文献综述。
Expert Opin Ther Pat. 2021 Dec;31(12):1155-1176. doi: 10.1080/13543776.2021.1945580. Epub 2021 Jul 27.
8
Incidence and risk factors for venous thromboembolism in a cohort of Taiwanese patients with lung, gastric, pancreatic cancers or lymphoma.台湾地区肺癌、胃癌、胰腺癌或淋巴瘤患者队列中静脉血栓栓塞症的发生率及相关风险因素。
J Formos Med Assoc. 2022 Jan;121(1 Pt 2):360-366. doi: 10.1016/j.jfma.2021.04.025. Epub 2021 May 13.
9
The Intrinsic Pathway does not Contribute to Activation of Coagulation in Mice Bearing Human Pancreatic Tumors Expressing Tissue Factor.
Thromb Haemost. 2021 Jul;121(7):967-970. doi: 10.1055/s-0040-1722193. Epub 2021 Jan 14.
10
Venous thromboembolism in cancer patients: a population-based cohort study.癌症患者的静脉血栓栓塞症:一项基于人群的队列研究。
Blood. 2021 Apr 8;137(14):1959-1969. doi: 10.1182/blood.2020007338.